ORTHOCELL LIMITED - Announcements

Market Cap $80.59M Add to my watchlist

Healthcare Biotechnology

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes CelGro, Striate+, Remplir, and SmrtGraft. CelGro is a collagen medical device that facilitates tissue reconstruction and healing in a variety of dental and orthopedic reconstructive applications. CelGro is manufactured using a SMRT manufacturing process to preserve the natural collagen structure. Striate+ is used for dental GBR applications. Remplir is for peripheral nerve reconstruction. SmrtGraft is for tendon repair. Its other major products are autologous cell therapy, which focuses on regenerating damaged tendon and cartilage tissue. It is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

OCC	Outstanding 98.6% Success Rate in Striate Implant Study	PRICE SENSITIVE	14/05/24	261.74KB	Share
OCC	Compelling 85% Success Rate Remplir Study now published		30/04/24	241.94KB	Share
OCC	Change of Director's Interest Notice-John Van Der Wielen		24/04/24	195.72KB	Share
OCC	Securities Trading Policy		24/04/24	266.3KB	Share
OCC	Change of Director's Interest Notice-John Van Der Wielen		16/04/24	195.7KB	Share
OCC	Orthocell receives $3.05m R&D tax incentive refund	PRICE SENSITIVE	15/04/24	198.23KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	08/04/24	591.72KB	Share
OCC	Part 1 Remplir US Market Authorisation Successfully Complete	PRICE SENSITIVE	25/03/24	255.02KB	Share
OCC	Cleansing Notice		11/03/24	118.28KB	Share
OCC	Application for quotation of securities - OCC		11/03/24	17.87KB	Share
OCC	Application for quotation of securities - OCC		11/03/24	18KB	Share
OCC	Cleansing Notice		28/02/24	118.59KB	Share
OCC	Application for quotation of securities - OCC		28/02/24	17.37KB	Share
OCC	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	23/02/24	5.64MB	Share
OCC	Proposed issue of securities - OCC		22/02/24	15.31KB	Share
OCC	Strategic Placement to Raise $3.5 million	PRICE SENSITIVE	22/02/24	209.64KB	Share
OCC	Trading Halt	PRICE SENSITIVE	20/02/24	559.11KB	Share
OCC	Remplir Expansion Continues with Singapore Application	PRICE SENSITIVE	13/02/24	215.05KB	Share
OCC	Notification of cessation of securities - OCC		06/02/24	13.94KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	29/01/24	544.01KB	Share
OCC	Appendix 3Y - Kim Beazley		17/01/24	193.75KB	Share
OCC	Notification regarding unquoted securities - OCC		17/01/24	29.51KB	Share
OCC	Final Director's Interest Notice		16/01/24	183.16KB	Share
OCC	Orthocell Board Changes		15/01/24	185.52KB	Share
OCC	Initial Director's Interest Notice - Mr Kim Beazley		15/01/24	163.02KB	Share
OCC	Proposed issue of securities - OCC		15/01/24	25.75KB	Share
OCC	The Hon Kim Beazley AC Joins Orthocell Board		15/01/24	189.23KB	Share
OCC	Final Director's Interest Notice		22/12/23	245.88KB	Share
OCC	Orthocell Board Change		22/12/23	183.39KB	Share
OCC	Change of Director's Interest Notice - Prof Fiona Wood		20/11/23	194.97KB	Share
OCC	Notification regarding unquoted securities - OCC		20/11/23	29.49KB	Share
OCC	Change of Director's Interest Notice-John Van Der Wielen		15/11/23	195.7KB	Share
OCC	Cleansing Notice		15/11/23	119.08KB	Share
OCC	Application for quotation of securities - OCC		15/11/23	26.57KB	Share
OCC	Successful OrthoATI clinical trial	PRICE SENSITIVE	14/11/23	369.21KB	Share
OCC	Change of Director's Interest Notice - Paul Anderson		07/11/23	197.07KB	Share
OCC	Notification regarding unquoted securities - OCC		07/11/23	29.77KB	Share
OCC	Change of Director's Interest Notice-John Van Der Wielen		06/11/23	193.45KB	Share
OCC	Initial Director's Interest Notice - Prof Fiona Wood		01/11/23	163.28KB	Share
OCC	Final Director's Interest Notice		01/11/23	175.82KB	Share
OCC	Replacement Constitution		31/10/23	533.62KB	Share
OCC	Results of Annual General Meeting		31/10/23	186.75KB	Share
OCC	AGM Addresses by Chair and Managing Director		31/10/23	339.72KB	Share
OCC	Cleansing Notice		30/10/23	119.09KB	Share
OCC	Application for quotation of securities - OCC		30/10/23	26.61KB	Share
OCC	UWA Royalty Entitlement Exchanged for Shares in Orthocell	PRICE SENSITIVE	30/10/23	197.39KB	Share
OCC	Proposed issue of securities - OCC		30/10/23	24.51KB	Share
OCC	Proposed issue of securities - OCC		25/10/23	25.75KB	Share
OCC	Professor Fiona Wood AM joins Orthocell Board		25/10/23	230.48KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	17/10/23	436.76KB	Share
OCC	Notification of cessation of securities - OCC		09/10/23	22.67KB	Share
OCC	Final Director's Interest Notice		02/10/23	184.42KB	Share
OCC	Proposed issue of securities - OCC		27/09/23	27.32KB	Share
OCC	Annual Report to Shareholders		27/09/23	6MB	Share
OCC	Notice of Annual General Meeting/Proxy Form		27/09/23	970.04KB	Share
OCC	Letter to Shareholders - Annual General Meeting		27/09/23	274.93KB	Share
OCC	Final Director's Interest Notice		22/09/23	252.85KB	Share
OCC	Orthocell Board Changes		22/09/23	168.78KB	Share
OCC	Date of AGM & Closing Date for Director Nominations		04/09/23	110.36KB	Share
OCC	Appendix 4G		31/08/23	283.2KB	Share
OCC	Corporate Governance Statement		31/08/23	318.09KB	Share
OCC	Appendix 4E & Annual Report	PRICE SENSITIVE	31/08/23	6.17MB	Share
OCC	Striate re-certified under new European medical device regs	PRICE SENSITIVE	24/08/23	187.74KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	31/07/23	619.49KB	Share
OCC	Orthocell receives A$3.17m R&D tax incentive refund	PRICE SENSITIVE	21/06/23	192.17KB	Share
OCC	Change of Director's Interest Notice - Paul Anderson		16/06/23	196.24KB	Share
OCC	Change of Director's Interest Notice - Paul Anderson		13/06/23	196.29KB	Share
OCC	Initial Director's Interest Notice - John Van Der Wielen		01/06/23	243.04KB	Share
OCC	Proposed issue of securities - OCC		29/05/23	24.81KB	Share
OCC	Notification regarding unquoted securities - OCC		29/05/23	29.37KB	Share
OCC	John Van Der Wielen appointed Independent Non-Exec Chair		29/05/23	230.27KB	Share
OCC	Option Terms and Conditions		26/05/23	176.17KB	Share
OCC	Notification regarding unquoted securities - OCC		26/05/23	32.74KB	Share
OCC	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	27/04/23	453.45KB	Share
OCC	Cleansing Notice		19/04/23	147.23KB	Share
OCC	Application for quotation of securities - OCC		19/04/23	25.11KB	Share
OCC	Notification regarding unquoted securities - OCC		19/04/23	31.68KB	Share
OCC	Orthocell commences nerve repair study	PRICE SENSITIVE	18/04/23	204.15KB	Share
OCC	Leading US-based nerve surgeons appointed to advisory board	PRICE SENSITIVE	29/03/23	169.54KB	Share
OCC	Initial Director's Interest Notice-RT		08/03/23	241.27KB	Share
OCC	Notification regarding unquoted securities - OCC		08/03/23	28.09KB	Share
OCC	Orthocell Appoints Non-Executive Director Dr Ravi Thadhani		08/03/23	231.18KB	Share
OCC	Orthocell appoints Company Secretary Mr Peter Webse		01/03/23	132.61KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/23	4.16MB	Share
OCC	Investor Presentation		02/02/23	12.22MB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	30/01/23	456.15KB	Share
OCC	Change of Director's Interest Notice PA		23/11/22	196.01KB	Share
OCC	Change of Director's Interest Notice LL		23/11/22	197.93KB	Share
OCC	Notification of cessation of securities - OCC		23/11/22	22.56KB	Share
OCC	Notification of cessation of securities - OCC		23/11/22	22.49KB	Share
OCC	Change of Director's Interest Notice LL Revised		11/11/22	320.85KB	Share
OCC	Change of Director's Interest Notice LL		09/11/22	198.1KB	Share
OCC	Remplir Gains Australian Reimbursement	PRICE SENSITIVE	01/11/22	299.94KB	Share
OCC	Appendix 4C - Quarterly	PRICE SENSITIVE	31/10/22	442.67KB	Share
OCC	Results of Meeting		28/10/22	140.26KB	Share
OCC	Investor Presentation		26/10/22	5.72MB	Share
OCC	OrthoATI Rotator Cuff Study Success With Cross-Over Patients	PRICE SENSITIVE	29/09/22	273.87KB	Share
OCC	Letter to Shareholders - Annual General Meeting		28/09/22	727.9KB	Share
OCC	Notice of Annual General Meeting/Proxy Form		28/09/22	851.1KB	Share
OCC	First orders for Striate and Remplir	PRICE SENSITIVE	27/09/22	185.26KB	Share

OCC Outstanding 98.6% Success Rate in Striate Implant Study
14/05/24	PRICE SENSITIVE	261.74KB	Share
OCC Compelling 85% Success Rate Remplir Study now published
30/04/24		241.94KB	Share
OCC Change of Director's Interest Notice-John Van Der Wielen
24/04/24		195.72KB	Share
OCC Securities Trading Policy
24/04/24		266.3KB	Share
OCC Change of Director's Interest Notice-John Van Der Wielen
16/04/24		195.7KB	Share
OCC Orthocell receives $3.05m R&D tax incentive refund
15/04/24	PRICE SENSITIVE	198.23KB	Share
OCC Quarterly Activity Report & Appendix 4C
08/04/24	PRICE SENSITIVE	591.72KB	Share
OCC Part 1 Remplir US Market Authorisation Successfully Complete
25/03/24	PRICE SENSITIVE	255.02KB	Share
OCC Cleansing Notice
11/03/24		118.28KB	Share
OCC Application for quotation of securities - OCC
11/03/24		17.87KB	Share
OCC Application for quotation of securities - OCC
11/03/24		18KB	Share
OCC Cleansing Notice
28/02/24		118.59KB	Share
OCC Application for quotation of securities - OCC
28/02/24		17.37KB	Share
OCC Appendix 4D & Half-Year Financial Statements
23/02/24	PRICE SENSITIVE	5.64MB	Share
OCC Proposed issue of securities - OCC
22/02/24		15.31KB	Share
OCC Strategic Placement to Raise $3.5 million
22/02/24	PRICE SENSITIVE	209.64KB	Share
OCC Trading Halt
20/02/24	PRICE SENSITIVE	559.11KB	Share
OCC Remplir Expansion Continues with Singapore Application
13/02/24	PRICE SENSITIVE	215.05KB	Share
OCC Notification of cessation of securities - OCC
06/02/24		13.94KB	Share
OCC Quarterly Activity Report & Appendix 4C
29/01/24	PRICE SENSITIVE	544.01KB	Share
OCC Appendix 3Y - Kim Beazley
17/01/24		193.75KB	Share
OCC Notification regarding unquoted securities - OCC
17/01/24		29.51KB	Share
OCC Final Director's Interest Notice
16/01/24		183.16KB	Share
OCC Orthocell Board Changes
15/01/24		185.52KB	Share
OCC Initial Director's Interest Notice - Mr Kim Beazley
15/01/24		163.02KB	Share
OCC Proposed issue of securities - OCC
15/01/24		25.75KB	Share
OCC The Hon Kim Beazley AC Joins Orthocell Board
15/01/24		189.23KB	Share
OCC Final Director's Interest Notice
22/12/23		245.88KB	Share
OCC Orthocell Board Change
22/12/23		183.39KB	Share
OCC Change of Director's Interest Notice - Prof Fiona Wood
20/11/23		194.97KB	Share
OCC Notification regarding unquoted securities - OCC
20/11/23		29.49KB	Share
OCC Change of Director's Interest Notice-John Van Der Wielen
15/11/23		195.7KB	Share
OCC Cleansing Notice
15/11/23		119.08KB	Share
OCC Application for quotation of securities - OCC
15/11/23		26.57KB	Share
OCC Successful OrthoATI clinical trial
14/11/23	PRICE SENSITIVE	369.21KB	Share
OCC Change of Director's Interest Notice - Paul Anderson
07/11/23		197.07KB	Share
OCC Notification regarding unquoted securities - OCC
07/11/23		29.77KB	Share
OCC Change of Director's Interest Notice-John Van Der Wielen
06/11/23		193.45KB	Share
OCC Initial Director's Interest Notice - Prof Fiona Wood
01/11/23		163.28KB	Share
OCC Final Director's Interest Notice
01/11/23		175.82KB	Share
OCC Replacement Constitution
31/10/23		533.62KB	Share
OCC Results of Annual General Meeting
31/10/23		186.75KB	Share
OCC AGM Addresses by Chair and Managing Director
31/10/23		339.72KB	Share
OCC Cleansing Notice
30/10/23		119.09KB	Share
OCC Application for quotation of securities - OCC
30/10/23		26.61KB	Share
OCC UWA Royalty Entitlement Exchanged for Shares in Orthocell
30/10/23	PRICE SENSITIVE	197.39KB	Share
OCC Proposed issue of securities - OCC
30/10/23		24.51KB	Share
OCC Proposed issue of securities - OCC
25/10/23		25.75KB	Share
OCC Professor Fiona Wood AM joins Orthocell Board
25/10/23		230.48KB	Share
OCC Quarterly Activity Report & Appendix 4C
17/10/23	PRICE SENSITIVE	436.76KB	Share
OCC Notification of cessation of securities - OCC
09/10/23		22.67KB	Share
OCC Final Director's Interest Notice
02/10/23		184.42KB	Share
OCC Proposed issue of securities - OCC
27/09/23		27.32KB	Share
OCC Annual Report to Shareholders
27/09/23		6MB	Share
OCC Notice of Annual General Meeting/Proxy Form
27/09/23		970.04KB	Share
OCC Letter to Shareholders - Annual General Meeting
27/09/23		274.93KB	Share
OCC Final Director's Interest Notice
22/09/23		252.85KB	Share
OCC Orthocell Board Changes
22/09/23		168.78KB	Share
OCC Date of AGM & Closing Date for Director Nominations
04/09/23		110.36KB	Share
OCC Appendix 4G
31/08/23		283.2KB	Share
OCC Corporate Governance Statement
31/08/23		318.09KB	Share
OCC Appendix 4E & Annual Report
31/08/23	PRICE SENSITIVE	6.17MB	Share
OCC Striate re-certified under new European medical device regs
24/08/23	PRICE SENSITIVE	187.74KB	Share
OCC Quarterly Activity Report & Appendix 4C
31/07/23	PRICE SENSITIVE	619.49KB	Share
OCC Orthocell receives A$3.17m R&D tax incentive refund
21/06/23	PRICE SENSITIVE	192.17KB	Share
OCC Change of Director's Interest Notice - Paul Anderson
16/06/23		196.24KB	Share
OCC Change of Director's Interest Notice - Paul Anderson
13/06/23		196.29KB	Share
OCC Initial Director's Interest Notice - John Van Der Wielen
01/06/23		243.04KB	Share
OCC Proposed issue of securities - OCC
29/05/23		24.81KB	Share
OCC Notification regarding unquoted securities - OCC
29/05/23		29.37KB	Share
OCC John Van Der Wielen appointed Independent Non-Exec Chair
29/05/23		230.27KB	Share
OCC Option Terms and Conditions
26/05/23		176.17KB	Share
OCC Notification regarding unquoted securities - OCC
26/05/23		32.74KB	Share
OCC Quarterly Activity Report & Appendix 4C
27/04/23	PRICE SENSITIVE	453.45KB	Share
OCC Cleansing Notice
19/04/23		147.23KB	Share
OCC Application for quotation of securities - OCC
19/04/23		25.11KB	Share
OCC Notification regarding unquoted securities - OCC
19/04/23		31.68KB	Share
OCC Orthocell commences nerve repair study
18/04/23	PRICE SENSITIVE	204.15KB	Share
OCC Leading US-based nerve surgeons appointed to advisory board
29/03/23	PRICE SENSITIVE	169.54KB	Share
OCC Initial Director's Interest Notice-RT
08/03/23		241.27KB	Share
OCC Notification regarding unquoted securities - OCC
08/03/23		28.09KB	Share
OCC Orthocell Appoints Non-Executive Director Dr Ravi Thadhani
08/03/23		231.18KB	Share
OCC Orthocell appoints Company Secretary Mr Peter Webse
01/03/23		132.61KB	Share
OCC Half Yearly Report and Accounts
28/02/23	PRICE SENSITIVE	4.16MB	Share
OCC Investor Presentation
02/02/23		12.22MB	Share
OCC Appendix 4C - Quarterly
30/01/23	PRICE SENSITIVE	456.15KB	Share
OCC Change of Director's Interest Notice PA
23/11/22		196.01KB	Share
OCC Change of Director's Interest Notice LL
23/11/22		197.93KB	Share
OCC Notification of cessation of securities - OCC
23/11/22		22.56KB	Share
OCC Notification of cessation of securities - OCC
23/11/22		22.49KB	Share
OCC Change of Director's Interest Notice LL Revised
11/11/22		320.85KB	Share
OCC Change of Director's Interest Notice LL
09/11/22		198.1KB	Share
OCC Remplir Gains Australian Reimbursement
01/11/22	PRICE SENSITIVE	299.94KB	Share
OCC Appendix 4C - Quarterly
31/10/22	PRICE SENSITIVE	442.67KB	Share
OCC Results of Meeting
28/10/22		140.26KB	Share
OCC Investor Presentation
26/10/22		5.72MB	Share
OCC OrthoATI Rotator Cuff Study Success With Cross-Over Patients
29/09/22	PRICE SENSITIVE	273.87KB	Share
OCC Letter to Shareholders - Annual General Meeting
28/09/22		727.9KB	Share
OCC Notice of Annual General Meeting/Proxy Form
28/09/22		851.1KB	Share
OCC First orders for Striate and Remplir
27/09/22	PRICE SENSITIVE	185.26KB	Share

REFRESH

1 2 3 4 5

(20min delay)
Last 38.5¢		Change 0.005(1.32%)		Mkt cap ! $80.59M

Open	High	Low	Value	Volume
38.0¢	38.5¢	38.0¢	$10.3K	26.83K

Buyers (Bids)

No.	Vol.	Price($)
2	3551	38.5¢

Sellers (Offers)

Price($)	Vol.	No.
39.0¢	14559	1

View Market Depth

No.	Vol.	Price($)
2	3551	0.385
6	42050	0.380
2	105604	0.375
6	96929	0.370
6	128310	0.365

Price($)	Vol.	No.
0.390	14559	1
0.400	16267	3
0.405	62993	6
0.410	103646	8
0.415	15700	2

Last trade - 13.46pm 16/05/2024 (20 minute delay)


Last 38.5¢		Change 0.005 ( 0.00 %)
Open	High	Low	Volume
38.0¢	38.5¢	38.0¢	18729
Last updated 13.46pm 16/05/2024 ?

OCC (ASX) Chart

ORTHOCELL LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available